✦ LIBER ✦

PDB15 COMPARATIVE COST-UTILITY ANALYSIS OF LONG-ACTING INSULIN ANALOGUE (INSULIN DETEMIR) AND NPH INSULIN FOR THE TREATMENT OF TYPE 1 AND TYPE 2 DIABETES AND THE BUDGET IMPACT ANALYSIS OF INSULIN ANALOGUE REIMBURSEMENT IN POLAND

✍ Scribed by J Walczak; D Pawlik; A Jasinska; M Garbacka; J Kedzior; T Fundament; I Malczak; W Dardzinski; I Skrzekowska-Baran; M Czech; G Nogas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin therapy in type 2 diabetes: role

✍ H. Yki-Järvinen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

PDB23 Budget Impact Analysis of the Reim

✍ Orlewska, E.; Gulacsi, L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PDB3 COST-EFFECTIVENESS ANALYSIS OF INSU

✍ I Smith; AJ Palmer; S Roze; T Kennedy-Martin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PDB22 ECONOMIC EVALUATION OF LONG-ACTING

✍ D Belanger; CG Cameron 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PDB21 COST-EFFECTIVENESS OF INSULIN DETE

✍ ME Minshall; SL Tunis; C Conner; J McCormick; JI Kapor; D Grole 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PDB10 COST-MINIMIZATION ANALYSIS COMPARI

✍ Bahia, L; Teich, V 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB